People: Valneva SE (VLS.PA)
Dr. Wolfgang Bender M.D., Ph.D., is Chief Medical Officer, Member of the Executive Committee and Member of the Management Board of the Company. He is a global life sciences leader with over 30 years of extensive experience in scientific-medical affairs, R&D and general management of vaccines and pharmaceuticals. He has a broad international profile with an exceptional academic background (MD/PhD, MPH, MHA, DTM&P). He has special competencies in strategy, operational execution and change management, with a record of success working in leadership roles for leading global life sciences companies. He held a variety of senior and international positions in vaccine development and medical affairs, working for leading companies in the field, including Novartis Vaccines and Takeda Vaccines. Prior positions included country manager, corporate strategy and various clinical research roles at major pharmaceutical companies such as Pfizer and the Hoechst Group.
|Total Annual Compensation, EUR||326,208|
|Restricted Stock Award, EUR||--|
|Long-Term Incentive Plans, EUR||--|
|All Other, EUR||40,768|
|Fiscal Year Total, EUR||366,976|